These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1206464)

  • 41. [Influence of vehicles on human skin permeation of norgestrel and levonorgestrel in vitro].
    Zhong JP; Zhou RR; Chen GS; Wang Y; Wang JG
    Yao Xue Xue Bao; 1991; 26(12):933-7. PubMed ID: 1823994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cosmeceutical vehicles.
    Epstein H
    Clin Dermatol; 2009; 27(5):453-60. PubMed ID: 19695476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The pharmacokinetics of external skin preparations].
    Wohlrab W; Wozniak KD; Taube KM
    Pharmazie; 1984 Sep; 39(9):614-5. PubMed ID: 6504996
    [No Abstract]   [Full Text] [Related]  

  • 44. [Studies on the percutaneous absorption and the systemic effects of corticosteroids in rats--with special reference to the relation between distribution and change of organs].
    Suzuki M
    Nihon Hifuka Gakkai Zasshi; 1984 Jun; 94(7):831-43. PubMed ID: 6492449
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacologic effects of adrenal corticosteroids.
    N Engl J Med; 1965 Oct; 273(16):875-6. PubMed ID: 5825908
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of percutaneous absorption by the use of volatile: nonvolatile systems as vehicles.
    Coldman MF; Poulsen BJ; Higuchi T
    J Pharm Sci; 1969 Sep; 58(9):1098-102. PubMed ID: 5346073
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of crystallinity on the percutaneous absorption of corticosteroid. II. Chemical activity and biological activity.
    Morita M; Hirota S
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2091-7. PubMed ID: 4053233
    [No Abstract]   [Full Text] [Related]  

  • 48. Percutaneous steroid absorption in anhidrosis.
    Solomon LM; Altman AT
    J Invest Dermatol; 1969 Dec; 53(6):454-7. PubMed ID: 5361579
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide.
    Barrett CW; Hadgraft JW; Caron GA; Sarkany I
    Br J Dermatol; 1965 Nov; 77(11):576-8. PubMed ID: 5853251
    [No Abstract]   [Full Text] [Related]  

  • 50. [Availability of active substances in and on the skin. Comparative study of the liberation and penetration of various cyproterone and cyproterone acetate ointments].
    Kotwas J; Schaefer H; Zesch A
    Arzneimittelforschung; 1979; 29(3):562-8. PubMed ID: 582747
    [No Abstract]   [Full Text] [Related]  

  • 51. Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.
    Ostrenga J; Steinmetz C; Poulsen B
    J Pharm Sci; 1971 Aug; 60(8):1175-9. PubMed ID: 5127090
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of vehicles on percutaneous absorption. IV. Errata and addenda: effect of vehicles on percutaneous absorption I--III.
    Oishi H; Ushio Y; Narahara K; Takehara M; Nakagawa T
    Chem Pharm Bull (Tokyo); 1977 Jul; 25(7):1833-6. PubMed ID: 908100
    [No Abstract]   [Full Text] [Related]  

  • 53. [Formulation parameters, skin permeability and drug penetration].
    Zecchi V; Rodriguez L; Cini M; Viti V
    Farmaco Prat; 1978 Jan; 33(1):34-40. PubMed ID: 624379
    [No Abstract]   [Full Text] [Related]  

  • 54. The percutaneous absorption and disposition of the antibacterial agent bronopol in rats and rabbits.
    Risdall PC; Risdall PC; Moore DH; Chasselaud LF
    Food Cosmet Toxicol; 1976 Jun; 14(3):189-92. PubMed ID: 950212
    [No Abstract]   [Full Text] [Related]  

  • 55. Determination of vehicle effects on percutaneous absorption by laser Doppler velocimetry.
    Guy RH; Tur E; Schall LM; Elamir S; Maibach HI
    Arch Dermatol Res; 1986; 278(6):500-2. PubMed ID: 2947545
    [No Abstract]   [Full Text] [Related]  

  • 56. Propylene glycol.
    Goldsmith LA
    Int J Dermatol; 1978 Nov; 17(9):703-5. PubMed ID: 365810
    [No Abstract]   [Full Text] [Related]  

  • 57. The rate of absorption and duration of action of four different solutions of methyl nicotinate.
    Fountain RB; Baker BS; Hadgraft JW; Sarkany I
    Br J Dermatol; 1969 Mar; 81(3):202-6. PubMed ID: 5775069
    [No Abstract]   [Full Text] [Related]  

  • 58. [Percutaneous penetration].
    Hunziker N; Brun MR
    Rev Med Suisse Romande; 1976 May; 96(5):363-70. PubMed ID: 1013554
    [No Abstract]   [Full Text] [Related]  

  • 59. ESTERGEL, A NEW BASE FOR DERMATOLOGIC USE.
    SMITH GC
    J S C Med Assoc; 1965 Aug; 61():223-4. PubMed ID: 14335149
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of vehicles on percutaneous absorption. III. Simulation and measurement of input data.
    Takehara M; Nakagawa T; Ushio Y; Narahara K; Oishi H
    Chem Pharm Bull (Tokyo); 1976 Aug; 24(8):1779-83. PubMed ID: 975434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.